Moody’s assigns ‘Aa2’ and ‘Aa2/VMIG 1’ ratings to Ascension Health’s bonds

Moody’s Investors Service has assigned “Aa2” and “Aa2/VMIG 1” ratings to St. Louis-based Ascension Health’s proposed series 2016 bonds.

Advertisement

The rating assignment is based on several factors, including Ascension’s status as the largest nonprofit healthcare system in the U.S. with $21 billion in total operating revenues.

Ascension’s challenges include moderate operating margins and competition in most of its markets.

The outlook is stable, reflecting Moody’s Investors Service’s expectations that Ascension’s improved margins will be sustained.

Moody’s also affirmed ratings on approximately $5 billion of Ascension’s outstanding debt.

More articles on healthcare finance:
CMS unveils new risk-based primary care model: 13 things to know
Moody’s affirms Milford Regional Medical Center’s ‘Baa3’ rating
Moody’s assigns ‘Aa2′ rating to University of Iowa Hospitals and Clinics’ bonds

 

 


Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.